-+ 0.00%
-+ 0.00%
-+ 0.00%

Laboratorios Richmond Swings to Q3 2026 Net Profit of ARS 8.72 Billion

PUBT·11/05/2026 18:48:13
Listen to the news
Laboratorios Richmond Swings to Q3 2026 Net Profit of ARS 8.72 Billion
  • Laboratorios Richmond swung to third-quarter 2026 net income of AR$ 8.72 billion from a year-earlier loss.
  • Net sales rose 22% year over year to AR$ 50.19 billion.
  • Nine-month 2026 operating profit fell 47% to AR$ 12.11 billion due to AR$ 13.85 billion in unabsorbed VIDA plant costs.
  • Deliveries under a US$ 5.6 million order for the VIDA segment began in October 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laboratorios Richmond SACIF published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.